1. Home
  2. NVAX vs MBIN Comparison

NVAX vs MBIN Comparison

Compare NVAX & MBIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • MBIN
  • Stock Information
  • Founded
  • NVAX 1987
  • MBIN 1990
  • Country
  • NVAX United States
  • MBIN United States
  • Employees
  • NVAX N/A
  • MBIN N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • MBIN Major Banks
  • Sector
  • NVAX Health Care
  • MBIN Finance
  • Exchange
  • NVAX Nasdaq
  • MBIN Nasdaq
  • Market Cap
  • NVAX 1.3B
  • MBIN 1.5B
  • IPO Year
  • NVAX 1995
  • MBIN 2017
  • Fundamental
  • Price
  • NVAX $9.23
  • MBIN $32.06
  • Analyst Decision
  • NVAX Buy
  • MBIN Buy
  • Analyst Count
  • NVAX 7
  • MBIN 3
  • Target Price
  • NVAX $14.29
  • MBIN $40.00
  • AVG Volume (30 Days)
  • NVAX 4.4M
  • MBIN 141.7K
  • Earning Date
  • NVAX 11-11-2025
  • MBIN 10-27-2025
  • Dividend Yield
  • NVAX N/A
  • MBIN 1.24%
  • EPS Growth
  • NVAX N/A
  • MBIN N/A
  • EPS
  • NVAX 2.54
  • MBIN 4.55
  • Revenue
  • NVAX $1,078,718,000.00
  • MBIN $598,079,000.00
  • Revenue This Year
  • NVAX $60.81
  • MBIN $4.09
  • Revenue Next Year
  • NVAX N/A
  • MBIN $7.88
  • P/E Ratio
  • NVAX $3.62
  • MBIN $7.09
  • Revenue Growth
  • NVAX 9.22
  • MBIN N/A
  • 52 Week Low
  • NVAX $5.01
  • MBIN $27.25
  • 52 Week High
  • NVAX $13.77
  • MBIN $46.78
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 60.85
  • MBIN 48.48
  • Support Level
  • NVAX $8.32
  • MBIN $31.23
  • Resistance Level
  • NVAX $9.05
  • MBIN $32.85
  • Average True Range (ATR)
  • NVAX 0.41
  • MBIN 0.77
  • MACD
  • NVAX 0.06
  • MBIN 0.01
  • Stochastic Oscillator
  • NVAX 68.06
  • MBIN 41.88

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About MBIN Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

Share on Social Networks: